Neurolief receives FDA PMA Approval for First At-Home Brain Neuromodulation Therapy for Adults Whose Depression Was Not Adequately Improved by Antidepres…

Neurolief Inc., a medical device company focused on neuromodulation therapies for neuropsychiatric conditions, today ...
Medical Dialogues

FDA Approves First At-Home Brain Neuromodulation Device for Depression

The FDA has approved ProlivRx, the first prescription, home-based brain neuromodulation therapy, as an adjunctive treatment ...
EurekAlert!

International Neuromodulation Society 16th World Congress to be Held in Vancouver in May 2024

Vancouver, BC – The International Neuromodulation Society (INS) announces its 16th Scientific World Congress in the breathtaking city of Vancouver, Canada, from May 11-16, 2024. This event, ...
Nasdaq

Helius Announces Positive Outcome of the Portable Neuromodulation Stimulator PoNS® Stroke Registrational Program and Upcoming Submission to FDA Under Breakthrough Designation

NEWTOWN, Pa., July 21, 2025 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and ...
UC San Francisco

When Depression Meds Don’t Work, This May Help You Turn the Corner

Some 30% to 40% of patients do not respond to medications for depression and obsessive-compulsive disorder (OCD), but half of them could be helped by a noninvasive in-office procedure. To mark ...
Morningstar

Publication in Alzheimer’s & Dementia Elucidates Multimodal Mechanism of Action Underpinning Promising New Neuromodulation Therapy for Alzheimer’s

Review publication details benefits of repetitive transcranial magnetic stimulation (rTMS) on Alzheimer’s, including increases in neuroplasticity and other structural and functional second order ...
BioWorld

Improved neuromodulation technique for treating urinary tract dysfunction

The Belgian academic Stefan De Wachter is seeking patent protection for methods of ensuring pelvic health and treating a disease or disorder characterized by a dysfunctional autonomic nervous system ...
MarketWatch

Publication in Alzheimer's & Dementia Elucidates Multimodal Mechanism of Action Underpinning Promising New Neuromodulation Therapy for Alzheimer's

The MarketWatch News Department was not involved in the creation of this content. Review publication details benefits of repetitive transcranial magnetic stimulation (rTMS) on Alzheimer's, including ...